Unknown

Dataset Information

0

TDP-43 promotes tau accumulation and selective neurotoxicity in bigenic Caenorhabditis elegans.


ABSTRACT: Although amyloid β (Aβ) and tau aggregates define the neuropathology of Alzheimer's disease (AD), TDP-43 has recently emerged as a co-morbid pathology in more than half of patients with AD. Individuals with concomitant Aβ, tau and TDP-43 pathology experience accelerated cognitive decline and worsened brain atrophy, but the molecular mechanisms of TDP-43 neurotoxicity in AD are unknown. Synergistic interactions among Aβ, tau and TDP-43 may be responsible for worsened disease outcomes. To study the biology underlying this process, we have developed new models of protein co-morbidity using the simple animal Caenorhabditis elegans. We demonstrate that TDP-43 specifically enhances tau but not Aβ neurotoxicity, resulting in neuronal dysfunction, pathological tau accumulation and selective neurodegeneration. Furthermore, we find that synergism between tau and TDP-43 is rescued by loss-of-function of the robust tau modifier sut-2. Our results implicate enhanced tau neurotoxicity as the primary driver underlying worsened clinical and neuropathological phenotypes in AD with TDP-43 pathology, and identify cell-type specific sensitivities to co-morbid tau and TDP-43. Determining the relationship between co-morbid TDP-43 and tau is crucial to understand, and ultimately treat, mixed pathology AD.

SUBMITTER: Latimer CS 

PROVIDER: S-EPMC9066518 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

TDP-43 promotes tau accumulation and selective neurotoxicity in bigenic Caenorhabditis elegans.

Latimer Caitlin S CS   Stair Jade G JG   Hincks Joshua C JC   Currey Heather N HN   Bird Thomas D TD   Keene C Dirk CD   Kraemer Brian C BC   Liachko Nicole F NF  

Disease models & mechanisms 20220427 4


Although amyloid β (Aβ) and tau aggregates define the neuropathology of Alzheimer's disease (AD), TDP-43 has recently emerged as a co-morbid pathology in more than half of patients with AD. Individuals with concomitant Aβ, tau and TDP-43 pathology experience accelerated cognitive decline and worsened brain atrophy, but the molecular mechanisms of TDP-43 neurotoxicity in AD are unknown. Synergistic interactions among Aβ, tau and TDP-43 may be responsible for worsened disease outcomes. To study th  ...[more]

Similar Datasets

| S-EPMC3075589 | biostudies-literature
| S-EPMC4282642 | biostudies-literature
| S-EPMC2722225 | biostudies-literature
| S-EPMC3390363 | biostudies-literature
| S-EPMC4256087 | biostudies-literature
| S-EPMC8496285 | biostudies-literature
| S-EPMC5837500 | biostudies-literature
2013-01-22 | E-GEOD-42844 | biostudies-arrayexpress
| S-EPMC3584124 | biostudies-literature
| S-EPMC10134869 | biostudies-literature